A B S T R A C r The turnover of the four major erythrocyte phospholipids has been studied with 32P, both in vivo and in vitro, in man and the dog. Phosphatidyl serine and phosphatidyl ethanolamine appeared to be stable erythrocyte lipids in both species. Turnover of the phosphate moiety of lecithin and sphingomyelin in the circulating erythrocytes of these two species seems entirely due to an exchange of the whole molecule with the corresponding plasma compound. Exchangeable and nonexchangeable pools of these two cellular lipids were found. In man about 60%o of erythrocyte lecithin is exchaigeable. The 12 hr fractional turnover of this pool is approximately 13%. Only 30% of the sphingomyelin in human cells appeared exchangeable; this portion had a 12 hr fractional turnover of about 14%o. Similar results were obtained in the dog except that in this species about 75%o of the erythrocyte sphingomyelin was exchangeable. Inorganic 32P was not incorporated into any of the four major phospholipids in either species. The present findings aid in estimating quantitatively the effect of plasmaerythrocyte lipid exchange on red blood cell phospholipids.
A B S T R A C r The turnover of the four major erythrocyte phospholipids has been studied with 32P, both in vivo and in vitro, in man and the dog. Phosphatidyl serine and phosphatidyl ethanolamine appeared to be stable erythrocyte lipids in both species. Turnover of the phosphate moiety of lecithin and sphingomyelin in the circulating erythrocytes of these two species seems entirely due to an exchange of the whole molecule with the corresponding plasma compound. Exchangeable and nonexchangeable pools of these two cellular lipids were found. In man about 60%o of erythrocyte lecithin is exchaigeable. The 12 hr fractional turnover of this pool is approximately 13%. Only 30% of the sphingomyelin in human cells appeared exchangeable; this portion had a 12 hr fractional turnover of about 14%o. Similar results were obtained in the dog except that in this species about 75%o of the erythrocyte sphingomyelin was exchangeable. Inorganic 32P was not incorporated into any of the four major phospholipids in either species. The present findings aid in estimating quantitatively the effect of plasmaerythrocyte lipid exchange on red blood cell phospholipids. INTRODUCTION There is now substantial agreement about the major classes and amounts of lipids present in human erythrocytes (2) . While hemoglobin and A preliminary report of this work has been presented previously (1) .
Received for publication 8 August 1967 and in revised form 30 November 1967. structural membrane protein are thought to be stable within the life-span of the circulating mature red blood cell (RBC) (3, 4) , a number of reports have indicated that some exchange of erythrocyte lipid with corresponding plasma compounds occurs in various species. Hevesey and Hahn, using the rabbit, (5) were the first to describe an exchange of phospholipids between erythrocytes and plasma. These workers (6) also suggested that the process was probably a slow one, and that all of the erythrocyte phospholipids were not involved equally. British workers have presented suggestive in vitro evidence that phospholipid exchange between cells and plasma occurs in human blood (7, 8) . More recently such an exchange has been described in the rat by several groups (9) (10) (11) . In all of the above reports the description of the process has been primarily qualitative, and actual rates of exchange for the individual phospholipids have not been determined.
The present study describes the dynamic state of the phosphate moiety of the four individual major phospholipids of circulating erythrocytes (sphingomyelin, lecithin, phosphatidyl ethanolamine, and phosphatidyl serine) in quantitative terms. The dog and man were studied by using 32p as a label. The results of short-term in vitro studies of plasma and erythrocyte phospholipid exchange are compared to results obtained from more prolonged in vivo observations. It was found that erythrocyte lecithin and sphingomyelin exchange with the corresponding plasma compounds in both species, and it was possible to determine the rate of these processes. In addition, exchangeable and nonexchangeable fractions of The Journal of Clinical Investigation Volume 47 1968 erythrocyte sphingomyelin and lecithin were found to exist. In contrast to these two lipids, phosphatidyl ethanolamine and phosphatidyl serine appeared to be stable membrane lipids.
METHODS
Normal human donors, patients with uncomplicated polycythemia rubra vera who had received therapeutic orthophosphate-32P, and mongrel dogs were used as subjects. Blood was collected into Na2EDTA (1.25 mg/ml of blood). The red blood cells were washed three times in 5 volumes of cold 0.17 M NaCl and the buffy coat was carefully removed each time. The white blood cell count was less than 500 per cubic mm and platelets were absent from the washed cells. The erythrocyte and plasma lipids were extracted, separated, and quantitated by chromatography on silicic acid-impregnated paper as previously described (12) . A modification in the preparation of the silicic acid-impregnated papers was used:
the papers were given a final wash in a 1/4% aqueous solution of Na2EDTA (w/v), air dried, and then stored at 60'C for 24 hr. The presence of the retained Na2EDTA and the mild heating improved the separation and definition of the phospholipid spots obtained after chromatography.
In the early experiments reported here, the total lipid extracts were directly chromatographed on paper. Later in the study, the total lipid extracts were first separated into two fractions before paper chromatography. This was accomplished as follows: about 10 mg of total lipid extract in benzene was applied to a silicic acid column (I.D. 8 mm, 1.5 g of 100 mesh silicic acid). The first fraction was eluated with 20 ml of chloroform-methanol, 4 :1 (v/v). This fraction contained the neutral lipids, phosphatidic acid, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and, rarely, small amounts of lecithin. The second fraction was eluted with 20 ml of methanol-water, 99: 1 (v/v); it contained lysolecithin, sphingomyelin, and lecithin. The column chromatography was carried out at 4°C under nitrogen. This initial fractionation procedure facilitated the complete separation of phosphatidyl inositol and sphingomyelin, and permitted final separation of larger amounts of phospholipid by paper chromatography than was possible when the total extract was chromatographed directly.
4-10 ,g of lipid phosphorus was applied to each paper chromatogram. These were developed by ascending chromatography at 4-6°C for 16-18 hr with a solvent consisting of 2,6-dimethyl-4-heptanone, n-butyl ether, acetic acid, and water, 20:20:20:3 (v/v). The phospholipids were identified by their color under ultraviolet light after they had been stained with Rhodamine 6-G, by their reaction to ninhydrin and choline spot tests, and by their relative mobilities, as described previously for this system (12, 13) . The individual lipid spots were cut out, and their radioactivity was measured using a low-background, thin window, gas-flow detector system.' The '-Model C 110-B, Nuclear-Chicago Corporation, Des Plains, Ill. background was less than 2 cpm with this system which allowed the determination of very low levels of labeling.
The lipid phosphorus was eluted from the spots with 0.5 N HCl at 65°C (12) . The phosphorus content of the eluates was determined by the method of Bartlett (14) . The lipid spots from four to six chromatograms were used to determine each specific activity. Sufficient counts were accumulated so that the standard error of the mean specific activities of sphingomyelin and lecithin (reported below) determined in this way were 5% or less. At least 500 counts were accumulated before deciding that a lipid was not labeled at all. Corrections for physical decay of the "P were made every 24 hr. Fig. 1 metabolic shaker, for periods of up to 12 hr. Sterile conditions were maintained and were confirmed by culture. Penicillin (100 units/ml) and streptomycin (0.1 mg/ml) were used in some of the incubation and had no effect on the results. Sufficient glucose was added to provide a total concentration of 12 umoles/ml of blood. Some of the incubations were carried out with plasma lipids dispersed in an aqueous buffer. The neutral lipids were first removed by silicic acid chromatography and elution with chloroform. The phosphatides were recovered from the column by elution with methanol, and then suspended, with a tissue homogenizer, in a buffer consisting of 5.9 X 10' M KH2PO4, 2.5 X 10' M Na2HPO4, 1.4 X 10' M NaCl, and 1 X 10i M MgSO4, with a resulting pH of 7.4. This suspension of the plasma phosphatides, usually 50 ml in volume, was then subjected to ultrasonic irradiation for 20 min with a dipping probe which generated energy at 20 kc/sec at a power output of 120 watts. The beaker containing the suspension was surrounded by ice water, and the temperature of the suspension remained at 100C or less during the sonication, although it might have been higher locally, immediately adjacent to the probe. This treatment produced a waterclear solution of the phosphatides, and the concentrations of lecithin and sphingomyelin in the buffer were the same before and after irradiation in each instance. The use of ultrasonic irradiation to produce stable, waterclear dispersions of phospholipids, without breakdown of the compounds, has been described, in detail, by Gammack, Perrin, and Saunders (15 packed normal erythrocytes from which the buffy coat had been removed. The mixture was incubated for 3 min at room temperature and then centrifuged at 2,000 g for 10 min at 4VC. The supernatant fluid containing the dispersed plasma phospholipids was recovered and then used in test incubations with additional normal erythrocytes. The preliminary absorption procedure served to remove any metallic particles introduced from the probe during the ultrasonic treatment, and to monitor the extent to which the dispersed phospholipids might adhere immediately, in a nonspecific manner, to the red blood cell surfaces. When labeled plasma phospholipids were used no radioactivity was found in the phosphatides of the adsorbing erythrocytes after 3 min, nor in the lipids of the test erythrocytes at time zero. Plasma was dialyzed against 20-50 volumes of 0.17 M NaC1 for 48 hr at 4°C, with three changes of the dialysate. Packed cell volumes were determined by the microhematocrit technique.
RESULTS
When orthophosphate-32P was administered in vivo, the label appeared promptly in the plasma lipid phosphorus; it appeared more slowly and at a lower level in the RBC phospholipids. The general pattern observed in both humans and dogs is shown in Fig. 2 . It can be seen that labeled plasma and RBC can be harvested for in vitro studies over a period of days after a single administration of the isotope. Fig. 3 shows the typical labeling PLASMA PHOSPHOLIPID DAYS FIGURE 2 Appearance of radioactivity in human plasma and erythrocyte lipid P after 'P administration. Orthophosphate-'P (0.15 mc/kg) was given as a single oral dose. The specific activity of the total plasma and erythrocyte lipid P was determined, as shown, over a period of 10 days. plasma lipid phosphorus in both Fig. 4 shows that radioactivity appeared in the the plasma nonlipid phosphorus, erythrocyte lipid phosphorus and that it increased rhich can be removed by dialysis. at a nearly constant rate for a period of 12 hr, on between plasma and erythrocyte at 370C. Little radioactivity was found in the was studied in vitro by incubating erythrocyte lipids when the incubations were carried out at 4VC. This ratio can be expressed as a percentage by multiplying the RSA by 100. In each instance, SAC(o) was zero. The SA of plasma sphingomyelin and lecithin decreased very little during these experiments; they were approximately 95% of the time zero values for both lipids in each case at the end of 12 hr. Thus, SAp was virtually constant. Column 2 of Table I shows that prior removal by dialysis of the plasma nonlipid phosphorus had no effect on the labeling achieved by erythrocyte lecithin and sphingomyelin. Column 3 of Table I shows that labeled plasma phospholipids, dispersed in an aqueous buffer at approximately the same concentration as they were present in native plasma, produced the same degree of labeling of the erythrocyte phospholipids as was found with whole plasma. Column 4 of the table shows that when orthophosphate-32P was added to the incubation mixtures as the only source of isotope there was no incorporation of radioactivity in any of the four major erythrocyte phosphatides over a period of 12 hr. All of these results indicate that plasma dialyzable phosphorus and inorganic phosphorus play no part in the labeling of the major erythrocyte phospholipids and that the plasma phosphatides are the sole immediate precursors in the labeling of the corresponding erythrocyte compounds.
The relative specific activities of erythrocyte lecithin and sphingomyelin shown in Table I are small (less than 10%) and, therefore, these product-precursor specific activity ratios are a good approximation of the actual fractional turnover per 12 hr of the cell phospholipids in the exchange process (16) The exchange of lecithin and sphingomyelin between plasma and erythrocytes was also studied by incubating cells which had become labeled in vivo (harvested 3-6 days after the initial administration of orthophosphate-32P, Fig. 2 ) with unlabeled plasma. In these experiments, labeling of the plasma lipid phosphorus increased at a constant rate for 12 hr and this period was, again, 2 Over a period of 12 hr and using Na2EDTA plasma in nonwettable surfaces, we found no evidence for the activity of the serum cholesterol-esterifying enzyme first described by Sperry (18) . In the presence of glass surfaces and over longer periods of incubation a reduction of serum lecithin and an increased amount of esterified cholesterol results from the activation of this enzyme (18, 19) .
Phospholipid Exchange between Plasma -and Erythrocytes chosen for analyzing the SA of the individual phosphatides.
It was possible to calculate the movement of RBC lecithin and sphingomyelin into the plasma from these experiments. The RSA's of the "product" compounds, plasma lecithin and sphingomyelin, were determined and this gave the fraction of the plasma lipid derived from the corresponding erythrocyte lipids at 12 hr. This value was multiplied by the total amount of the plasma lipid per ml of incubation mixture which gave the absolute amount of the lipid moving from the erythrocyte to the plasma compartment. This product was then divided by the amount of the lipid in the erythrocyte compartment, and the resulting quotient gave the fractional turnover of the erythrocyte lipid per 12 hr, measured in the outward direction. Combining the three steps, the expression for this calculation is: SAP(,)/SA, X ,gp X l/tgc (2) where , = jig of individual plasma lipid phosphorus per ml of incubation mixture Hgc = Ag of corresponding RBC lipid phosphorus per ml of incubation mixture, and the other symbols as in expression 1.
SAP(O), again, was zero, and, as mentioned, ,ugp and yg, did not change. The results of these outward studies are shown in the first column of Table II . It can be seen (Table II) that the fractional exchange rates and actual flows of erythrocyte sphingomyelin and lecithin calculated from both types of in vitro experiments do not agree, and that the rates determined from the outward studies are considerably larger. No net movement of lipid phosphorus between the erythrocyte and plasma compartments was discernible in these experiments, however, and the rates of actual lipid exchange should, therefore, be equal in both directions. The discrepancy between the calculated inward and outward rates may be resolved by assuming that the radioactivity in human erythrocyte lecithin and sphingomyelin, labeled in vivo, was not distributed uniformly throughout these lipid pools, but that it was distributed in only 63%o of the lecithin and 29% of the sphingomyelin. If obtained with the human material. Phosphatidyl serine and phosphatidyl ethanolamine were stable; sphingomyelin and lecithin were found to undergo exchange between the plasma and erythrocytes. The major difference found was that the size of the exchangeable sphingomyelin erythrocyte pool was larger in the dog. The distribution of sphingomyelin between plasma and erythrocytes is the same in both species, the plasma-erythrocyte molar ratio being approximately 1: 1. The observed difference may, therefore, be due to differences in The exchange process was also studied in vivo. Serial determinations of the SA of erythrocyte and plasma phospholipids were carried out in five patients and four dogs after the administration of orthophosphate-32P. Four of the humans and one dog received a single dose of the isotope. The other subjects received 32P in divided doses.
When the isotope was administered as an initial loading dose followed by small daily replacements, the SA of plasma lecithin and sphingomyelin could be kept nearly constant at a relatively high level for a period of days. Fig. 5 shows the SA of plasma lecithin and erythrocyte phosphatidyl serine and lecithin observed in a typical experiment in the dog when the isotope was administered in divided doses. The basic features of the exchange process seen in the in vitro studies are apparent in this type of experiment. The SA of plasma lecithin remained considerably higher than that of the RBC compounds, and it remained relatively constant from the 2nd to the 9th day. The SA of erythrocyte lecithin increased until about the 6th day and achieved a level which was 50-60% of the plasma lecithin SA. These findings suggest, qualitatively, that some fraction of the circulating erythrocyte lecithin pool exchanges very slowiy or not at all with plasma lecithin, as was indicated by the in vitro studies. The SA of phosphatidyl serine remained very low and was not measurable during the first 2 or 3 days. The labeling of this compound may be due to the influx of new cells from the bone marrow where phospholipid synthesis occurs (Fig. 1) .
In all the in vivo experiments a quantitative approximation of the fraction of erythrocyte lecithin or sphingomyelin which existed as labeled lipid on any given day was obtained by dividing the SA of the erythrocyte lipid on that day by the weighted average of the SA of the corresponding plasma lipid, to that point, according to the following expression: The fraction of the erythrocyte sphingomyelin or lecithin pools which are labeled (that is, the fraction of the erythrocyte lipids that was at one time in the plasma) can also be predicted exactly *"E" and "r" refer to the symbols in expression 4 of the text, and
were the values used in constructing the solid curves of Fig. 6 .
from the fractional turnover and sizes of the exchangeable erythrocyte pools determined in the in vitro studies, (Table IV) , by using this expression 3:
where t = time (12 hr = 1 unit) YC~) = fraction of the total individual RBC lipid pool which exists as labeled lipid at time t r = 12 hr fractional turnover rate of the exchangeable pool of the RBC lipid (Table  IV) that the low SA observed in phosphatidyl serine shown in Fig. 5 may serve as a rough guide to the effect of new cell synthesis, and that this is negligible for 6-9 days. (b) Removal of senescent erythrocytes from the circulation. About 1% per day of the circulating RBC mass will be removed this way in both man and the dog. This will tend to lower the observed labeling of circulating erythrocyte lecithin and sphingomyelin, but this effect should not be noticeable for 6-10 days. The fact that there was little deviation from the observed values and those predicted on the basis of exchange alone for as long as 15 days (Fig. 6) suggests that the opposite effects of new cell production and red cell senescence may tend to cancel each other.
DISCUSSION
In the present work some of the quantitative aspects of the exchange between erythrocyte lecithin and sphingomyelin with the corresponding plasma compounds have been described in man and the dog. These findings are summarized in Table IV . Exchangeable and nonexchangeable fractions of each of these two cellular lipids were found in both species. Rowe (8) has previously suggested that blood cellular lecithin, in humans, does not exchange completely with plasma lecithin.
It can be seen from Table IV that the turnover times of the exchangeable pools of erythrocyte sphingomyelin and lecithin, in both species, are approximately 5 days. Thus, alterations in the fatty acid composition of the plasma compounds can affect, in a very significant manner, the corresponding erythrocyte membrane lipids during the life span of a given red blood cell. The actual amounts of lipid involved in the exchange process, however, are quite small. In the case of lecithin, in both species studied here, the exchange is about 9 x 10-3 mmoles/liter of erythrocytes per hour. This is in contrast to the active transport of monovalent cations across the human erythrocyte membrane, for example, which is about 3 mmoles/liter of erythrocytes per hour.
In the present study, by using 32P to evaluate turnover, it was found that erythrocyte phosphatidyl serine was completely stable and phosphatidyl ethanolamine nearly so. As mentioned above, this may simply result from the virtual absence of these two phospholipids from the plasma of man and the dog. Erythrocyte cephalins have been found to be stable in exchange studies with 32P in the rat (10) where these compounds are also nearly absent from plasma. The different rates and degree of exchangeability found for sphingomyelin and lecithin, particularly in the human, on the other hand, suggest that, in addition to plasma concentration, the position of a lipid molecule in the membrane and the nature of its bond to membrane protein (ionic vs. hydrophobic) may also influence its exchange. Cholesterol, for example, is thought to be bound in many membranes only to the hydrophobic portion of phospholipids, primarily by the relatively weak van der Waals forces (20) . This erythrocyte lipid has been found to exchange very rapidly with plasma free cholesterol (turnover time less than 12 hr) in both man and the dog (21) (22) (23) . This is in contrast to the much slower rate of phospholipid exchange described here. The latter compounds probably are bound to membrane protein by charge-charge interactions, in large part (20) .
Inorganic 32p was not incorporated into any of the four major erythrocyte phospholipids. In these compounds, the phosphorus group exists as a diester and is internally placed in the molecule. Incorporation of inorganic 32P would, therefore, require enzymatic breakdown and resynthesis of the lipid. There is a substantial body of evidence, summarized by van Deenen and de Gier (2) , that mature nonnucleated erythrocytes are incapable of carrying out such synthetic lipid processes. For this reason, and because, as mentioned above, phosphoryl choline from lecithin did not appear in erythrocyte sphingomyelin, we believe that the exchange of lipid phosphorus herein described probably involves the entire lipid molecule.
Very small amounts of lysolecithin were found in the plasma and erythrocytes of both species studied. This compound was weakly labeled and its participation in the exchange process could not be evaluated. In the rat, on the other hand, substantial amounts of lysolecithin have been reported in the plasma and this compound is exchanged actively (9-11). Mulder and coworkers (24, 25) and, more recently, Tarlov (26) have indicated that reversible acylation by plasma fatty acids of membrane lysolecithin, a process known to occur in human red blood cells (27, 28) , accounts for a substantial proportion of lecithin turn-over in rat erythrocytes. The exact degree to which such transacylation of erythrocyte phospholipids occurs in human is not known at present. As suggested by Farquahar and Ahrens (29) , additional studies using phospholipids labeled with both 32P and 14C are needed to compare the contributions of transacylation and exchange of entire molecules to the dynamic state of the erythrocyte phospholipids.
The nonsymmetrical exchange of erythrocyte phospholipids described here is in contrast to the process of cellular lipid loss which has been reported during the course of in vivo ageing (30, 31) , during in vitro incubations of abnormal cells for 24 hr (17) , and in normal cells incubated for more prolonged periods (32) . In these instances, the loss of lipid has been found to involve all lipid compounds equally. The concomitant formation of small membrane fragments of varying sizes also observed in some of these studies (33) provided an explanation for the symmetrical nature of the lipid loss. The process of lipid exchange may, however, prove important in the pathogenesis of erythrocyte abnormalities associated with alterations in plasma lipids, as has been suggested previously (2, 26, 34) . It is hoped that the quantitative data on phospholipid exchange given in the present study may prove helpful in further exploration of this possibility.
